Subscribe to receive our Floor Reports covering all the action on the Texas House and Senate floor!
Relating to health benefit plan coverage of prescription drugs for stage-four advanced, metastatic cancer.
No significant fiscal implication to the State is anticipated relating to prescription drug coverage
for stage-four advanced, metastatic cancer. According to the Health and Human Services
Commission (HHSC), the fiscal implications of the bill cannot be determined at this time relating
to the uncertainty of prescription drug coverage for associated conditions of stage-four
advanced, metastatic cancer.
Texas Action opposes HB 1584 because it infringes on limited government principles. While this is an extremely sympathetic situation, we generally oppose governmental interference with private health benefit plan providers that mandates the type of coverage and mitigating processes that the provider is allowed or required to provide. The litany of these types of mandates have contributed to unaffordable health care costs and impeded access to health insurance. While this particular mandate might not raise overall rates perceptibly, it is the accumulation of many such mandates that have contributed to the problem.